Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

12.50p
   
  • Change Today:
      0.25p
  • 52 Week High: 40.00p
  • 52 Week Low: 7.45p
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 221,602
  • Market Cap: £37.98m
  • RiskGrade: 479

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
95.85% above the market average95.85% above the market average95.85% above the market average95.85% above the market average95.85% above the market average
86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
5.64% above the market average5.64% above the market average5.64% above the market average5.64% above the market average5.64% above the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Book Ratio
73.27% below the market average73.27% below the market average73.27% below the market average73.27% below the market average73.27% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
98.15% above the market average98.15% above the market average98.15% above the market average98.15% above the market average98.15% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Chg 3m
80.93% above the market average80.93% above the market average80.93% above the market average80.93% above the market average80.93% above the market average
64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
85.08% above the market average85.08% above the market average85.08% above the market average85.08% above the market average85.08% above the market average
75.61% above the sector average75.61% above the sector average75.61% above the sector average75.61% above the sector average75.61% above the sector average
Momentum 20
52.73% above the market average52.73% above the market average52.73% above the market average52.73% above the market average52.73% above the market average
56.10% above the sector average56.10% above the sector average56.10% above the sector average56.10% above the sector average56.10% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
0.08% above the market average0.08% above the market average0.08% above the market average0.08% above the market average0.08% above the market average
53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
17.98% below the market average17.98% below the market average17.98% below the market average17.98% below the market average17.98% below the market average
54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.42% below the market average35.42% below the market average35.42% below the market average35.42% below the market average35.42% below the market average
13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average
Operating Profit Loss
6.47% below the market average6.47% below the market average6.47% below the market average6.47% below the market average6.47% below the market average
59.09% above the sector average59.09% above the sector average59.09% above the sector average59.09% above the sector average59.09% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
33.07% below the market average33.07% below the market average33.07% below the market average33.07% below the market average33.07% below the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average
Cash
6.48% below the market average6.48% below the market average6.48% below the market average6.48% below the market average6.48% below the market average
20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
25.37% below the market average25.37% below the market average25.37% below the market average25.37% below the market average25.37% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Buys 1y
22.27% above the market average22.27% above the market average22.27% above the market average22.27% above the market average22.27% above the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
66.28% above the market average66.28% above the market average66.28% above the market average66.28% above the market average66.28% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 12.50p
Change Today 0.25p
% Change 2.04 %
52 Week High 40.00p
52 Week Low 7.45p
Volume 221,602
Shares Issued 303.83m
Market Cap £37.98m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.76% below the market average57.76% below the market average57.76% below the market average57.76% below the market average57.76% below the market average
6.98% below the sector average6.98% below the sector average6.98% below the sector average6.98% below the sector average6.98% below the sector average
Price Trend
89.39% below the market average89.39% below the market average89.39% below the market average89.39% below the market average89.39% below the market average
91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average
Income Not Available
Growth
25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average
26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
16:35 365 @ 12.50p
16:35 112 @ 12.50p
16:35 77 @ 12.50p
16:35 2 @ 12.50p
16:35 42 @ 12.50p

Futura Medical Key Personnel

Finance Director Angela Hildreth

Top of Page